InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Renee PremiumMember
03/30/22 7:10 PM
profile icon
Nisti Free
09/12/21 7:54 PM
profile icon
Nisti Free
08/28/21 9:09 PM
profile icon
Renee PremiumMember
12/19/18 9:17 AM
profile icon
Renee PremiumMember
11/21/18 5:54 PM
profile icon
Quintessence Free
10/10/18 2:03 PM
profile icon
Big Brother PremiumMember
10/10/18 7:36 AM
profile icon
Quintessence Free
10/09/18 6:33 PM
profile icon
Kicko Free
10/09/18 6:15 PM
profile icon
Quintessence Free
10/09/18 5:40 PM
profile icon
Quintessence Free
10/08/18 10:48 AM
profile icon
Quintessence Free
10/02/18 4:51 PM
profile icon
Big Brother PremiumMember
09/24/18 8:35 AM
profile icon
john12341 Free
09/13/18 5:29 PM
profile icon
UnderTheInfluence Free
09/13/18 12:14 PM
profile icon
john12341 Free
09/06/18 2:25 PM
profile icon
Quintessence Free
09/05/18 6:51 AM
profile icon
Quintessence Free
08/31/18 2:09 PM
profile icon
Quintessence Free
08/16/18 4:17 PM
profile icon
UnderTheInfluence Free
08/13/18 11:38 AM
profile icon
Zalmy Free
08/09/18 9:11 AM
profile icon
urbanredneck Free
12/06/17 10:38 AM
profile icon
Big Brother PremiumMember
10/31/17 10:46 AM
profile icon
Big Brother PremiumMember
08/30/17 10:49 AM
profile icon
urbanredneck Free
08/30/17 10:30 AM
profile icon
Big Brother PremiumMember
08/22/17 1:25 PM
profile icon
Big Brother PremiumMember
05/05/17 8:03 AM
profile icon
urbanredneck Free
03/31/17 2:34 PM
profile icon
Big Brother PremiumMember
01/05/17 7:44 AM
profile icon
Big Brother PremiumMember
01/04/17 12:11 PM
profile icon
Big Brother PremiumMember
01/04/17 11:30 AM
profile icon
Big Brother PremiumMember
12/27/16 11:40 AM
profile icon
Big Brother PremiumMember
12/23/16 1:53 PM
profile icon
Big Brother PremiumMember
12/22/16 1:53 PM
profile icon
Big Brother PremiumMember
12/18/16 1:53 PM
profile icon
Big Brother PremiumMember
12/14/16 1:25 PM
profile icon
Big Brother PremiumMember
12/13/16 10:13 AM
profile icon
Big Brother PremiumMember
12/10/16 4:04 PM
profile icon
Big Brother PremiumMember
12/09/16 4:29 PM
profile icon
Big Brother PremiumMember
12/09/16 7:52 AM
profile icon
Big Brother PremiumMember
12/08/16 3:41 PM
profile icon
Big Brother PremiumMember
12/08/16 2:53 PM
profile icon
Big Brother PremiumMember
12/08/16 1:32 PM
profile icon
Big Brother PremiumMember
12/08/16 12:29 PM
profile icon
Big Brother PremiumMember
12/08/16 11:59 AM

Gulf West Security Network Inc. (GWSN) RSS Feed

Followers
7
Posters
16
Posts (Today)
0
Posts (Total)
136
Created
04/23/15
Type
Free
Moderators

NuLife Sciences, Inc.

Company Website: (under construction, domain registered 10/26/16): http://www.NuLifeSciences.net
OTC Markets: http://www.otcmarkets.com/stock/SMFI/profile
Nevada SOS: http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=r6kBXez%252bxOtPtwfh7mJS5w%253d%253d


The NuLife Technique

With 15 years of committed research supporting the GandTex biomedical assets, NuLife will possess a unique patented proprietary method (newly branded as the "NuLife Technique") that could potentially eliminate the need for an organ or tissue match and the necessity for anti-rejection drugs in human organ transplant. With over 123K candidates waiting for an organ in the U.S. alone, the market need is significant especially considering the potential of utilizing discarded or marginal organs. Additionally, the Company's versatile technique is potentially suitable for a variety of clinical indications, including sepsis, organ failure, wound healing, and other critical health related issues that humans are challenged with today.

With the Discovery phase completed, NuLife intends to enter a preclinical phase involving animal experiments. Data derived from future clinical trials will be submitted to Federal Drug Administration (FDA), Institutional Review Boards (IRB) and/or other regulatory bodies to determine the final pathway to utilization and commercialization.

Upon regulatory approval and successful human surgeries via randomized clinical trials, NuLife plans to build a market for using discarded and marginal organs processed by the NuLife technique for transplantation. Once established and proven, NuLife will target Organ Procurement Organizations (OPO) in all 50 states who would purchase organs processed by NuLife and other centers focused on using the technique for transplantation. The Company believes that this new approach would have the potential to significantly improve the organ transplantation process by reducing the needs for matching as well as reducing the needs for dialysis for patients awaiting a donor organ. It is also expected to significantly reduce or potentially eliminate expenses and adverse events associated with anti-rejection medications.

Patents
Tissue Transplantation Involving, and Tissues Modified by Decellularization And Recellularization Of Donor Tissues For Minimized Or Obviated Rejection Reactions

Decellularization and recellularization of donor tissues for minimized or obviated rejection reactions 

http://patents.justia.com/inventor/james-bennie-gandy


NEWS:

West Monroe researcher develops new transplant method

Smoofi Provides Corporate Update; Acquires Assets Focused on Advancing Human Organ Transplant Technology and Medical Research


Share Structure
  Market Value1 $4,352,012 a/o Oct 28, 2016
Authorized Shares 200,000,000 a/o Oct 26, 2016
Outstanding Shares 31,085,800 a/o Oct 26, 2016
-Restricted 8,450,000 a/o Oct 26, 2016
-Unrestricted 22,635,800 a/o Oct 26, 2016
Held at DTC 3,361,994 a/o Oct 26, 2016
  Float 6,988,734 a/o May 08, 2015
 

Investor Relations
Ted Haberfield
MZ Group
President
MZ North America
Direct: 760-755-2716
Mobile: 858-204-5055
thaberfield@mzgroup.us 
www.mzgroup.us


 
 
 


 
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
GWSN Latest News
  • No Recent News Available for this company!
New Post